SMI
12.404,36
PKT
+106,01
PKT
+0,86
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.06.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 30.06.15 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 26.06.15 | Roche buy | HSBC | |
| 26.06.15 | Novartis buy | HSBC | |
| 24.06.15 | Roche overweight | JP Morgan Chase & Co. | |
| 24.06.15 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 24.06.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 24.06.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 24.06.15 | Nestlé buy | Citigroup Corp. | |
| 23.06.15 | Novartis buy | Citigroup Corp. | |
| 22.06.15 | Zurich Insurance buy | Jefferies & Company Inc. | |
| 19.06.15 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 19.06.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.06.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 17.06.15 | UBS buy | Deutsche Bank AG | |
| 17.06.15 | UBS buy | Deutsche Bank AG | |
| 17.06.15 | Nestlé Underperform | BNP PARIBAS | |
| 16.06.15 | Zurich Insurance Neutral | Citigroup Corp. | |
| 16.06.15 | Swiss Re buy | Citigroup Corp. | |
| 16.06.15 | Novartis buy | UBS AG | |
| 15.06.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 15.06.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 11.06.15 | Swiss Re buy | Citigroup Corp. | |
| 10.06.15 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 10.06.15 | UBS buy | Goldman Sachs Group Inc. | |
| 10.06.15 | Holcim buy | Deutsche Bank AG | |
| 10.06.15 | Holcim buy | Deutsche Bank AG | |
| 10.06.15 | UBS buy | Goldman Sachs Group Inc. | |
| 09.06.15 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 09.06.15 | Swiss Re Hold | Jefferies & Company Inc. | |
| 08.06.15 | Nestlé buy | Citigroup Corp. | |
| 08.06.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.06.15 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.06.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 05.06.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 05.06.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 04.06.15 | Novartis buy | Citigroup Corp. | |
| 03.06.15 | UBS Outperform | RBC Capital Markets | |
| 03.06.15 | Swiss Re buy | Kepler Cheuvreux | |
| 02.06.15 | Roche overweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.